Sensitivity to Endocrine Therapy Index Predicts Benefit from Weekly Adjuvant Paclitaxel for Hormone Receptor-Positive Breast Cancer in the GEICAM/9906 Trial. [PDF]
Martín M +25 more
europepmc +1 more source
Pharmacologic de-escalation of dexamethasone during weekly paclitaxel: a randomized phase III trial evaluating safety, endocrine effects, and quality of life. [PDF]
Scontre VA +2 more
europepmc +1 more source
3-Year Outcomes of Low-Dose vs High-Dose Drug-Coated Balloons in Femoropopliteal Artery Disease: The PROSPECT MONSTER Study. [PDF]
Nakama T +10 more
europepmc +1 more source
Successful Treatment of Recurrent Biliary Anastomotic Stricture with Drug-coated Balloon Dilation. [PDF]
Yeo MGH, Xiang H.
europepmc +1 more source
Real‑world analysis of Macular Oedema associated with Paclitaxel Formulations using the Japanese Adverse Drug Event Report database. [PDF]
Takeda K +5 more
europepmc +1 more source
Efficacy and Safety of First-Line Chemotherapy With Gemcitabine Plus Nab-Paclitaxel in Unresectable Gallbladder Cancer. [PDF]
Yang Y +11 more
europepmc +1 more source
Efficacy of nab-paclitaxel combined with immune checkpoint inhibitors in solid tumors: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Li X, Song Y, Li J.
europepmc +1 more source
Metastatic Testicular Cancer Complicated by Myelodysplastic Syndrome. [PDF]
Shimizu N +9 more
europepmc +1 more source
Sintilimab Combined With Albumin-Bound Paclitaxel and SOX Regimen as Conversion Therapy for Unresectable Advanced Gastric Cancer Achieving Complete Remission: A Case Report and Literature Review. [PDF]
Tang Y +8 more
europepmc +1 more source
Pathologic Complete Response Following Frailty-Adjusted Neoadjuvant Paclitaxel in an 88-Year-Old Patient With Radiation-Associated Breast Angiosarcoma. [PDF]
Brown AC +4 more
europepmc +1 more source

